Overview

Our Viral Vector Process Development service supports preclinical gene therapy and research programs with robust, scalable vector production up to 200 liters. Whether you need AAV, lentivirus, or retrovirus, we optimize the entire workflow—from DNA ratio to producer cell line generation—delivering reliable, high-yield vectors for translational research.

Why Choose Our Viral Vector Process Development Services?

● Scalable Production: Develop viral vectors at research or preclinical scale—up to 200L.
● Comprehensive Optimization: Fine-tune packaging ratios and processes for greater efficiency.
● QC-Focused: Viral genome copy number, host DNA, and residual DNA assessed via dqPCR or countable PCR.
● Integrated Technologies: Advanced viral labeling and cell painting tools available.

Applications

● Production of AAV, lentivirus, retrovirus, HSV, or adenovirus for gene therapy research
● Stable producer cell line development for consistent viral output
● Preclinical program support requiring scalable vector production
● Custom vector manufacturing for academic or early-stage biotech groups

Our Process

1. Consultation: Define project scope, viral system, and output needs.

2. Development: Optimize upstream and downstream processes in our lab.

3. Production: Deliver clean, scalable viral vector batches.

4. Reporting: Provide quality control and performance data for every batch.

Get Started

Let’s accelerate your gene therapy pipeline with precision-engineered viral vectors. Contact us to initiate a project.